Authors: Clarke-Pearson, DL Van Le, L Iveson, T Whitney, CW Hanjani, P Kristensen, G Malfetano, JH Beckman, RA Ross, GA Lane, SR DeWitte, MH Fields, SZ

Citation: Dl. Clarke-pearson et al., Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer, J CL ONCOL, 19(19), 2001, pp. 3967-3975

Authors: Gore, M Rustin, G Schuller, J Lane, SR Hearns, S Beckman, RA Ross, G

Citation: M. Gore et al., Topotecan given as a 21-day infusion in the treatment of advanced ovarian cancer, BR J CANC, 84(8), 2001, pp. 1043-1046

Authors: Beckman, RA Siden, R Yanik, GA Levine, JE

Citation: Ra. Beckman et al., Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child, J PED H ONC, 22(4), 2000, pp. 344-350

Authors: Akhtar, S Beckman, RA Mould, DR Doyle, E Fields, SZ Wright, J

Citation: S. Akhtar et al., Pretreatment with ranitidine does not reduce the bioavailability of orallyadministered topotecan, CANC CHEMOT, 46(3), 2000, pp. 204-210